Bristol-Myers Squibb and BioNTech announced a major deal worth up to $11 billion in early June. Click here to find out why I ...

A new COVID variant, NB 1.8.1, is being detected across California; here are the symptoms to watch for, and vaccinations ...

BMY teams with BioNTech on BNT327, a dual-target cancer therapy, as legacy drugs face mounting generic pressure ...

A new COVID variant, NB.1.8.1, was detected in Washington. These are the symptoms to watch for and recommended vaccinations.

The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...

Healthcare companies are navigating a challenging environment as policy uncertainty and competitive pressures weigh on the ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

With U.S. stocks booming, North American wealthy led the way globally. And the top 1% of wealthy globally—the so-called ...

The fraught discussions playing out between President Donald Trump and one of the world’s most powerful figures could shape ...

Experts say Robert F. Kennedy Jr. has talked about "freedom of choice" in health care while limiting choices on some products ...